Claims for Patent: 10,703,816

✉ Email this page to a colleague

Summary for Patent: 10,703,816

Title:	M971 chimeric antigen receptors
Abstract:	The invention provides a chimeric antigen receptor (CAR) comprising an antigen binding domain comprising SEQ ID NOs: 1-6, a transmembrane domain, and an intracellular T cell signaling domain. Nucleic acids, recombinant expression vectors, host cells, populations of cells, antibodies, or antigen binding portions thereof, and pharmaceutical compositions relating to the CARs are disclosed. Methods of detecting the presence of cancer in a mammal and methods of treating or preventing cancer in a mammal are also disclosed.
Inventor(s):	Rimas J. Orentas, Ira H. Pastan, Dimiter S. Dimitrov, Crystal L. Mackall
Assignee:	US Department of Health and Human Services
Application Number:	US16/107,271

Details for Patent 10,703,816

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Janssen Biotech, Inc.	STELARA	ustekinumab	Injection	125261	September 25, 2009	10,703,816	2038-08-21
Janssen Biotech, Inc.	STELARA	ustekinumab	Injection	125261	December 30, 2009	10,703,816	2038-08-21
Kite Pharma Inc.	YESCARTA	axicabtagene ciloleucel	Injection	125643	October 18, 2017	10,703,816	2038-08-21
Kite Pharma Inc.	TECARTUS	brexucabtagene autoleucel	For Injection	125703	July 24, 2020	10,703,816	2038-08-21
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,703,816

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2014065961	⤷ Get Started Free
United States of America	2024084008	⤷ Get Started Free
United States of America	2024084007	⤷ Get Started Free
United States of America	2020283522	⤷ Get Started Free
United States of America	2019085078	⤷ Get Started Free
United States of America	2015299317	⤷ Get Started Free
United States of America	11807682	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.